Cervical cancer screening in the United States and the Netherlands: A tale of two countries

Milbank Quarterly

Volumn 90, Issue 1, 2012, Pages 5-37

  Habbema, Dik ^a   De Kok, Inge M C M ^a   Brown, Martin L ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; clinical guidelines; comparative effectiveness; cross country study; economic efficiency; health care policy; pap testing; preventive services; screening

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; FEMALE; HIGH RISK POPULATION; HUMAN; MEDICAL SERVICE; NETHERLANDS; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES; UTERINE CERVIX CANCER;

ALPHAPAPILLOMAVIRUS; CROSS-CULTURAL COMPARISON; FEMALE; GUIDELINES AS TOPIC; HEALTH POLICY; HUMANS; INCIDENCE; MASS SCREENING; NETHERLANDS; PAPILLOMAVIRUS INFECTIONS; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PUBLIC HEALTH; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84859044078     PISSN: 0887378X     EISSN: 14680009     Source Type: Journal    
DOI: 10.1111/j.1468-0009.2011.00652.x     Document Type: Article

References (75)

1. ACOG (American Congress of Obstetricians and Gynecologists), Committee on Gynecologic Practice. 1995. ACOG Committee Opinion: Recommendations on Frequency of Pap Test Screening. International Journal of Gynecology & Obstetrics 49 (152): 210-11.
2. ACOG (American Congress of Obstetricians and Gynecologists), Committee on Practice Bulletins. 2003. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists. Cervical Cytology Screening (replaces committee opinion 152, March 1995). Obstetrics & Gynecology 102 (45): 417-27.
3. ACOG (American Congress of Obstetricians and Gynecologists). 2009a. ACOG Announces New Pap Smear and Cancer Screening Guidelines, November 20.
4. ACOG (American Congress of Obstetricians and Gynecologists), Committee on Practice Bulletins-Gynecology. 2009b. ACOG Practice Bulletin no. 109: Cervical Cytology Screening. Obstetrics & Gynecology 114: 1409-20.
5. Altekruse, S.F., C.L. Kosary, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, J. Ruhl, N. Howlader, Z. Tatalovich, H. Cho, A. Mariotto, M.P. Eisner, D.R. Lewis, K. Cronin, H.S. Chen, E.J. Feuer, D.G. Stinchcomb, and, B.K. Edwards,. 2010. SEER Cancer Statistics Review, 1975-2007. Available at http://seer.cancer.gov/csr/1975-2007/ (accessed February 10, 2011).
6. Anttila, A., L. von Karsa, A. Aasmaa, M. Fender, J. Patnick, M. Rebolj, F. Nicula, L. Vass, Z. Valerianova, L. Voti, C. Sauvaget, and, G. Ronco,. 2009. Cervical Cancer Screening Policies and Coverage in Europe. European Journal of Cancer 45: 2649-58.
7. Benard, V.B., M.S. Saraiya, A. Soman, K.B. Roland, K.R. Yabroff, and, J. Miller,. 2011. Breast and Cervical Cancer Screening Practices among Physicians in the National Breast and Cervical Cancer Early Detection Program. Journal of Women's Health 20: 1-6.
8. Bentley, T.G., R.M. Effros, K. Palar, and, E.B. Keeler,. 2008. Waste in the U.S. Health Care System: A Conceptual Framework. The Milbank Quarterly 86: 629-59.
9. Bos, A.B., M. van Ballegooijen, M.E. van den Akker-van Marle, A.G. Hanselaar, G.J. van Oortmarssen, and, J.D. Habbema,. 2001. Endocervical Status Is Not Predictive of the Incidence of Cervical Cancer in the Years after Negative Smears. American Journal of Clinical Pathology 115: 851-55. (Pubitemid 32476711)
10. Bos, A.B., M. van Ballegooijen, G.J. van Oortmarssen, and, J.D. Habbema,. 2002. Women Who Participate in Spontaneous Screening Are Not at Higher Risk for Cervical Cancer Than Women Who Attend Programme Screening. European Journal of Cancer 38: 827-31. (Pubitemid 34280329)
11. Brown, A.D., and, A.M. Garber,. 1999. Cost-Effectiveness of 3 Methods to Enhance the Sensitivity of Papanicolaou Testing. JAMA 281: 347-53. (Pubitemid 29061039)
12. Brown, M.L., S.J. Goldie, G. Draisma, J. Harford, and, J. Lipscomb,. 2006. Health Services Interventions for Cancer Control in Developing Countries. In Disease Control Priorities in Developing Countries, 2nd ed., ed., D.T. Jamison, 569-90. New York: Oxford University Press.
13. Buist, D., and, A. Williams, (principal investigators). 2010. Cancer Screening and Research in Community-Based Healthcare, grant no. 5RC2CA149576.
14. Casparie, M., A.T. Tiebosch, G. Burger, H. Blauwgeers, A. van de Pol, J.H. van Krieken, and, G.A. Meijer,. 2007. Pathology Databanking and Biobanking in the Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive. Cellular Oncology 29: 19-24. (Pubitemid 46535194)
15. Castle, P.E., 2011. Abuses in Human Papillomavirus DNA Testing. Obstetrics & Gynecology 118: 1-3.
16. Cohen, J.T., P.J. Neumann, and, M.C. Weinstein,. 2008. Does Preventive Care Save Money? Health Economics and the Presidential Candidates. New England Journal of Medicine 358: 661-63. (Pubitemid 351240744)
17. Cooper, C.P., M. Saraiya, T.A. McLean, J. Hannan, J.M. Liesmann, S.W. Rose, and, H.W. Lawson,. 2005. Report from the CDC. Pap Test Intervals Used by Physicians Serving Low-Income Women through the National Breast and Cervical Cancer Early Detection Program. Journal of Women's Health (Larchmont) 14: 670-78. (Pubitemid 41645628)
18. Coupe, V.M.H., J. Berkhof, N.W.J. Bulkmans, P.J.F. Snijders, and, C.J.L.M. Meijer,. 2008. Age-Dependent Prevalence of 14 High-Risk HPV Types in the Netherlands: Implications for Prophylactic Vaccination and Screening. British Journal of Cancer 98: 646-51. (Pubitemid 351214513)
19. Day, N.E., 1986. Screening for Squamous Cervical Cancer: Duration of Low Risk after Negative Results of Cervical Cytology and Its Implication for Screening Policies. BMJ 293: 659-64.
20. Dowling, E.C., C. Klabunde, J. Patnick, and, R. Ballard-Barbash, on behalf of the International Cancer Screening Network. 2010. Breast and Cervical Cancer Screening Programme Implementation in 16 Countries. Journal of Medical Screening 17: 139-46.
21. Dunne, E.F., E.R. Unger, M. Sternberg, G. McQuillan, D.S. Swan, S.S. Patel, and, L.E. Markowitz,. 2007. Prevalence of HPV Infection among Females in the United States. JAMA 297: 813-19. (Pubitemid 46333946)
22. Dutch Ministry of Health, Welfare, and Sports. 2010. Health Insurance System. Available at http://english.minvws.nl/en/themes/healthinsurance-system/ default.asp (accessed February 10, 2011).
23. Eddy, D.M., 1990. Screening for Cervical Cancer. Annals of Internal Medicine 113: 214-26. (Pubitemid 20242298)
24. Ekwueme, D.U., J.G. Gardner, S. Subramanian, F.K. Tangka, B. Bapat, and, L.C. Richardson,. 2008. Cost Analysis of the National Breast and Cervical Cancer Early Detection Program: Selected States, 2003 to 2004. Cancer 112: 626-35. (Pubitemid 351186203)
25. Evaluation Committee on Early Detection of Cervical Cancer. 1984. Report on the Second Round of the Mass Screening Program in the Pilot Regions Nijmegen, Rotterdam and Utrecht [in Dutch]. Leidschendam: Ministerie VOMIL.
26. Fahs, M.C., J. Mandelblatt, C. Schechter, and, C. Muller,. 1992. Cost Effectiveness of Cervical Cancer Screening for the Elderly. Annals of Internal Medicine 117: 520-27.
27. Gardner, J.W., and, J.L. Lyon,. 1977. Efficacy of Cervical Cytologic Screening in the Control of Cervical Cancer. Preventive Medicine 6: 487-99. (Pubitemid 8263036)
28. Grilli, R., N. Magrini, A. Penna, G. Mura, and, A. Liberati,. 2000. Practice Guidelines Developed by Specialty Societies: The Need for a Critical Appraisal. The Lancet 355: 103-6. (Pubitemid 30068554)
29. Habbema, J.D.F., J.Th.N. Lubbe, H.M. van Agt, M.A. van Ballegooijen, M.A. Koopmanschap, and, G.J. van Oortmarssen,. 1988. Costs and Effects of the Organised Cervical Cancer Screening Programme [in Dutch]. Rotterdam: Department of Public Health, Erasmus University.
30. Hagen, M.D., A.M. Garber, S.J. Goldie, J.E. Lafata, J. Mandelblatt, D. Meltzer, P. Neumann, J.E. Siegel, H.C. Sox Jr., and, J. Tsevat,. 2001. Symposium: Does Cost-Effectiveness Analysis Make a Difference? Lessons from Pap Smears. Medical Decision Making 21: 307-23. (Pubitemid 32652494)
31. Health Council of the Netherlands. 2011. Screening for Cervical Cancer.
32. Howard, M., G. Agarwal, and, A. Lytwyn,. 2009. Accuracy of Self-Reports of Pap and Mammography Screening Compared to Medical Record: A Meta-analysis. Cancer Causes & Control 20: 1-13.
33. Imperiale, T.F., and, D.F. Ransohoff,. 2010. Understanding Differences in the Guidelines for Colorectal Cancer Screening. Gastroenterology 138: 1642-47e1.
34. Insinga, R.P., E.J. Dasbach, and, E.H. Elbasha,. 2005. Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US. Pharmacoeconomics 23: 1107-22. (Pubitemid 41633402)
35. Insinga, R.P., A.G. Glass, and, B.B. Rush,. 2004. Pap Screening in a U.S. Health Plan. Cancer Epidemiology, Biomarkers & Prevention 13: 355-60. (Pubitemid 38737458)
36. Jacobzone, S., and, M. Hughes,. 2002. Summary of Results from Breast Cancer Disease Study. Paris: Organization for Economic Co-operation and Development.
37. Kaiser Permanente National Cervical Cancer Screening Guideline Development Team. 2006. Cervical Cancer Screening Guideline. Oakland, CA: Kaiser Permanente Care Management Institute. Available at http://www.guideline.gov/ content.aspx?id=10713 (accessed February 13, 2012).
38. Kim, J.J., T.C. Wright, and, S.J. Goldie,. 2002. Cost-Effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance. JAMA 287: 2382-90. (Pubitemid 34493201)
39. Lee, J.W, Z. Berkowitz, and, M. Saraiya,. 2011. Low-Risk Human Papillomavirus Testing and Other Nonrecommended Human Papillomavirus Testing Practices among U.S. Health Care Providers. Obstetrics & Gynecology 118: 4-12.
40. Leyden, W.A., M.M. Manos, A.M. Geiger, S. Weimann, J. Mouchawar, K. Bischoff, M.U. Yood, J. Gilbert, and, S.H. Taplin,. 2005. Cervical Cancer in Women with Comprehensive Health Care Access: Attributable Factors in the Screening Process. Journal of the National Cancer Institute 97: 675-83. (Pubitemid 40812631)
41. Medicare.gov. 2011. Cervical and Vaginal Cancer Screenings. http://www.medicare.gov/navigation/manage-your-health/preventiveservices/ cervical-cancer-screening.aspx?AspxAutoDetectCookie-Support=1 (accessed November 5, 2011).
42. Meissner, H.I., J.A. Tiro, D. Haggstrom, G. Lu-Yao, and, N. Breen,. 2008. Does Patient Health and Hysterectomy Status Influence Cervical Cancer Screening in Older Women? Journal of General Internal Medicine 23: 1822-28.
43. Ministry of Welfare, Health and Culture. 1991. Letter PEP/GZ 001027 on Cervical Cancer Screening to the National Health Insurance Council. The Netherlands.
44. Moise, M., and, S. Jacobzone., 2003. OECD Study of Cross-National Differences in the Treatment, Costs and Outcomes of Ischaemic Heart Disease. Paris: OECD Health Working Papers no. 3, April 22.
45. Moise, P., M. Schwarzinger, and, M.-Y. Um,. 2004. Dementia Care in 9 OECD Countries: A Comparative Analysis. Paris: OECD Health Working Papers no. 13, July 28.
46. Moon, L., P. Moise, and, S. Jacobzone,. 2003. Stroke Care in OECD Countries: A Comparison of Treatments, Costs and Outcomes in 17 Countries. Paris: OECD Health Working Papers no. 5, June 6.
47. National Center for Health Statistics. 2011a. National Health Interview Survey, Methods. Available at http://www.cdc.gov/nchs/nhis/methods.htm (accessed February 10, 2011).
48. National Center for Health Statistics. 2011b. National Health Interview Survey, NHIS Questionnaires 1962-1996, 1997-Present. Available at (accessed February 10, 2011).
49. National Health Insurance Council. 1993. Principles for the Restructuring of the Organised Cervical Cancer Screening Programme-Final Decision [in Dutch]. Amstelveen: ZiekenfondsRaad.
50. National Institute for Public Health and the Environment (RIVM). 2010. Available at http://www.rivm.nl/en/aboutrivm/ (accessed February 10, 2011).
51. Netherlands Cancer Registry. 2010. Incidence and Mortality Figures Cervical Cancer, 1970-2008 [in Dutch]. Available at www.iknl.nl (accessed November 4, 2011).
52. Pearson, S.D., and, P.B. Bach,. 2010. How Medicare Could Use Comparative Effectiveness Research in Deciding on New Coverage and Reimbursement. Health Affairs (Millwood) 29: 1796-804.
53. Rebolj, M., M. van Ballegooijen, L.M. Berkers, and, J.D. Habbema,. 2007. Monitoring a National Cancer Prevention Program: Successful Changes in Cervical Cancer Screening in the Netherlands. International Journal of Cancer 120: 806-12. (Pubitemid 46175400)
54. Rebolj, M., M. van Ballegooijen, F. van Kemenade, C. Looman, R. Boer, and, J.D. Habbema,. 2008. No Increased Risk for Cervical Cancer after a Broader Definition of a Negative Pap Smear. International Journal of Cancer 123: 2632-35.
55. Roland, K.B, A. Soman, V.B. Benard, and, M. Saraiya,. 2011. Human Papillomavirus and Papanicolaou Tests Screening Interval Recommendations in the United States. American Journal of Obstetrics & Gynecology, June 12 [epub ahead of print.
56. Saraiya, M., Z. Berkowitz, K.R. Yabroff, L. Wideroff, S. Kobrin, and, V. Benard,. 2010. Cervical Cancer Screening with Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone: What Screening Intervals Are Physicians Recommending? Archives of Internal Medicine 170: 977-85.
57. Saraiya, M., L.F. McCaig, and, D.U. Ekwueme,. 2010. Ambulatory Care Visits for Pap Tests, Abnormal Pap Test Results, and Cervical Cancer Procedures in the United States. American Journal of Managed Care 16: e137-44.
58. Saslow, D., C.D. Runowicz, D. Solomon, A. Moscicki, R.A. Smith, H.J. Eyre, and, C. Cohen,. 2002. American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. CA Cancer Journal for Clinicians 52: 342-62. (Pubitemid 35446606)
59. Sawaya, G.F., K.J. McConnell, S.L. Kulasingam, H.W. Lawson, K. Kerlikowske, J. Melnikow, N.C. Lee, G. Gildengorin, E.R. Myers, and, A.E Washington,. 2003. Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings. New England Journal of Medicine 349: 1501-9. (Pubitemid 37255035)
60. Statistics Netherlands (CBS). 2010a. Death by Cause of Death, Age and Sex 1970-2009 [in Dutch]. Available at http://statline.cbs.nl/StatWeb (accessed November 4, 2011).
61. Statistics Netherlands (CBS). 2010b. Population: Age, Sex, Marital Status per January 1 [in Dutch]. Available at http://statline.cbs.nl/StatWeb
62. Swan, J., N. Breen, B.I. Graubard, T.S. McNeel, D. Blackman, F.K. Tangka, and, R. Ballard-Barbash,. 2010. Data and Trends in Cancer Screening in the United States: Results from the 2005 National Health Interview Survey. Cancer 116: 4872-81.
63. Tangka, F.K., B. O'Hara, J.G. Gardner, J. Turner, J. Royalty, K. Shaw, S. Sabatino, I.J. Hall, and, R.J. Coates,. 2010. Meeting the Cervical Cancer Screening Needs of Underserved Women: The National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control 21: 1081-90.
64. U.S. Congress Office of Technology Assessment. 1990. The Costs and Effectiveness of Screening for Cervical Cancer in Elderly Women-Background Paper, OTA-BP-H-65. Washington, DC: U.S. Government Printing Office, February.
65. U.S. Department of Health, Education and Welfare. 1968. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Adapted for Use in the United States. 8th rev. Washington, DC: U.S. Department of Health, Education and Welfare, National Center for Health Statistics, Public Health Service.
66. USPSTF (U.S. Preventive Services Task Force). 2003. Screening for Cervical Cancer. Available at http://www.uspreventiveservicestaskforce.org/ uspstf/uspscerv.htm (accessed February 10, 2011).
67. van Ballegooijen, M., R. Boer, G. van Oortmarssen, M. Koopmanschap, J. Lubbe, and, J. Habbema,. 1993. Cervical Cancer Screening Programme: Age Ranges and Intervals. An Updated Cost-Effectiveness Analysis [in Dutch]. Rotterdam: Erasmus University, Department of Public Health.
68. van Ballegooijen, M., M. Rebolj, M. Essink-Bot, W. Meerding, L. Berkers, and, J. Habbema,. 2006. The Effects and Costs of the Cervical Cancer Screening Programme after Its Restructuring [in Dutch]. Rotterdam: Erasmus University, Department of Public Health.
69. van den Akker-van Marle, M.E., M. van Ballegooijen, and, J.D.F. Habbema,. 2003. Low Risk of Cervical Cancer during a Long Period after Negative Screening in the Netherlands. British Journal of Cancer 88: 1054-57. (Pubitemid 36560775)
70. Vogt, T.M., A. Glass, R.E. Glasgow, P.A. La Chance, and, E. Lichtenstein,. 2003. The Safety Net: A Cost-Effective Approach to Improving Breast and Cervical Cancer Screening. Journal of Women's Health (Larchmont) 12: 789-98. (Pubitemid 37361921)
71. Weinstein, M.C., and, J.A. Skinner,. 2010. Comparative Effectiveness and Health Care Spending-Implications for Reform. New England Journal of Medicine 362: 460-65.
72. WHO (World Health Organization). 1955. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Adapted for Use in the United States. 7th rev. Geneva.
73. WHO (World Health Organization). 1977. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Based on the Recommendations of the Ninth Revision Conference 1975. Geneva.
74. Wong, C., Z. Berkowitz, M. Saraiya, L. Wideroff, and, V.B. Benard,. 2010. US Physicians' Intentions Regarding Impact of Human Papillomavirus Vaccine on Cervical Cancer Screening. Sex Health 7: 338-45.
75. Yabroff, K.R., M. Saraiya, H.I. Meissner, D.A. Haggstrom, L. Wideroff, G. Yuan, Z. Berkowitz, W.W. Davis, V.B. Benard, and, S.S. Coughlin,. 2009. Specialty Differences in Primary Care Physician Reports of Papanicolaou Test Screening Practices: A National Survey, 2006 to 2007. Annals of Internal Medicine 151: 602-11.